Cerebral small vessel disease (SVD) is a leading cause of strokes and a significant contributor to dementia, yet the precise mechanisms underlying its pathogenesis remain elusive. In a recent whole-exome association study involving population cohorts with SVD, we identified a variant on TRIM47 locus. The ubiquitin ligase TRIM47 is highly expressed in brain endothelial cells (ECs), suggesting its potential role in blood brain barrier (BBB) integrity. Here, we show that TRIM47 regulates brain ECs resilience and adaptive responses to oxidative stress by binding to KEAP1, stabilizing NRF2 protein levels and promoting NRF2 antioxidant signaling pathway. In vivo, Trim47-deficient mice exhibit downregulation of NRF2 target genes, BBB dysfunction, astrogliosis and cognitive impairments. Endothelial-specific deletion of Trim47 recapitulates this vascular dementia phenotype, emphasizing the critical role of endothelial TRIM47 in protecting brain function. Treatment with the NRF2 activator tert-butylhydroquinone normalized BBB integrity and cognitive function in Trim47-deficient mice, highlighting the role of TRIM47 in driving brain homeostasis through NRF2 pathway activation. This work indicates that the loss of the protective TRIM47/NRF2 axis may increase the susceptibility to developing human SVD and that targeting the TRIM47/NRF2 axis could offer novel therapeutic strategies for vascular dementia and related neurovascular diseases.